Nanopharm to Host Webinar on April 21st Discussing In-Vitro Dissolution Testing for Orally-Inhaled Drug Products

Nanopharm Ltd will host an educational webinar entitled “Overcoming the Challenges in Developing an In-Vitro Dissolution and Release System for Orally-Inhaled Drug Products” on Tuesday, April 21, 2020 at 4 pm CET/10 am EST.

Presented by Prof. Rob Price, Chief Scientific Officer at Nanopharm Ltd, an Aptar Pharma company, this event is an opportunity for scientists, regulatory experts and senior managers to learn more about novel advanced analytical approaches for the characterization of orally-inhaled drug products. The webinar will cover the range of dissolution tests available, why they are important to consider, and how Nanopharm’s latest innovation – a new in-vitro release testing system – can help to accelerate and de-risk the development of orally-inhaled drug products.

This webinar is free-to-attend and will be available on-demand after the live presentation.

Register for Nanopharm’s webinar here.